GSK to hold on to its antibiotics business, but nearly 200 workers will go

GlaxoSmithKline is cutting sterile manufacturing jobs at its site in Ulverston, U.K. (GlaxoSmithKline)

It has been a tough rollercoaster ride for GlaxoSmithKline’s U.K. manufacturing site in Ulverston. Once slated to get a major biologics plant with hundreds of new jobs, GSK is now closing a part of the plant and laying off nearly 200 workers.

The cuts come as GSK has decided to keep its cephalosporins antibiotics business but reorganize it to be more efficient.